Skip to Content

Join the 'Breast Cancer - Male' group to help and get support from people like you.

Breast Cancer - Male News

Yoga, Meditation May Ease Some Breast Cancer Symptoms

Posted 19 May 2017 by Drugs.com

FRIDAY, May 19, 2017 – The diagnosis and treatment of breast cancer can come with a lot of anxiety, depression and other symptoms that affect quality of life. But mind-body therapies, such as yoga or meditation, may help ease these troubling concerns, a new study suggests. The researchers reviewed previous studies done on 80 integrative therapies. "We have good evidence that [some] mind-body therapies – such as meditation, yoga, relaxation – can provide benefit to breast cancer patients during and after treatment," said study researcher Heather Greenlee. She's an assistant professor of epidemiology at Columbia University's Mailman School of Public Health. "And we do have evidence that acupuncture is very useful in managing pain," she added. Evidence about dietary supplements and botanicals, however, are lacking when it comes to helping symptoms and side effects, she said. Greenlee ... Read more

Related support groups: Depression, Cancer, Major Depressive Disorder, Breast Cancer, Dysthymia, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Breast Cancer - Male, Osteolytic Bone Metastases of Breast Cancer

Survival Continues to Improve for Most Cancers

Posted 31 Mar 2017 by Drugs.com

FRIDAY, March 31, 2017 – Overall cancer death rates in the United States continue to fall, but racial gaps persist, a new report says. Death rates fell between 2010 and 2014 for 11 of the 16 most common cancers in men and for 13 of the most common types in women, including lung, colon, prostate and breast cancers. However, death rates rose for cancers of the liver, pancreas and brain in men and for the liver and uterus in women. And improvements in cancer survival weren't equal for all Americans. "While this report found that five-year survival for most types of cancer improved among both blacks and whites over the past several decades, racial disparities for many common cancers have persisted, and they may have increased for prostate cancer and female breast cancer," said Dr. Lynne Penberthy. She's associate director of the U.S. National Cancer Institute's Surveillance Research ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Renal Cell Carcinoma, Colorectal Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Metastatic, Brain Tumor, Melanoma, Skin Cancer, Ovarian Cancer, Pancreatic Cancer, Endometrial Cancer, Osteosarcoma, Small Cell Lung Cancer, Breast Cancer - Adjuvant, Bladder Cancer, Melanoma - Metastatic, Cervical Cancer

Could a Computer Someday Guide Breast Cancer Care?

Posted 9 Dec 2016 by Drugs.com

FRIDAY, Dec. 9, 2016 – An artificially intelligent computer system is making breast cancer treatment recommendations on a par with those of cancer doctors, a new study reports. The IBM computer system – called Watson Oncology – made treatment recommendations that jibed nine out of 10 times with those of a multidisciplinary board of doctors at a top cancer hospital in India, researchers say. In cases involving more complex cancers, however, the computer did not hit that 90 percent mark. Another version of Watson famously defeated two former winners on the game show "Jeopardy!" in 2011, winning a first-place prize of $1 million. In its oncology role, Watson digests a patient's medical history and current cancer data in under a minute. It then spends another minute reviewing all existing medical evidence regarding their particular form of cancer, said study co-author Dr. S.P. ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Breast Cancer - Male, Osteolytic Bone Metastases of Breast Cancer

Taking Breast Cancer Prevention Drug Beyond 5 Years May Not Raise Survival

Posted 7 Dec 2016 by Drugs.com

WEDNESDAY, Dec. 7, 2016 – Many breast cancer survivors take anti-estrogen drugs for at least five years to help lessen their risk of recurrence. Now, new research suggests that taking such a drug for an even longer period might not confer any added benefit – at least in terms of survival. The study of thousands of older breast cancer survivors found that taking the aromatase inhibitor drug letrozole (Femara) for more than the recommended five years did not help them live longer. However, other benefits were noted, so the decision to extend use of drugs like these is one best made on a case-by-case basis, cancer specialists said. One oncologist who reviewed the new findings said the study has been "eagerly awaited," since many breast cancer survivors are counseled to take an aromatase inhibitor. "For now, this trial reinforces the need to listen to our patients and weigh out the risk ... Read more

Related support groups: Breast Cancer, Arimidex, Femara, Breast Cancer, Metastatic, Anastrozole, Letrozole, Aromasin, Exemestane, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Breast Cancer - Male, Osteolytic Bone Metastases of Breast Cancer, Teslac, Testolactone

Cost of Breast Cancer Chemo Varies Widely in U.S.

Posted 10 Oct 2016 by Drugs.com

MONDAY, Oct. 10, 2016 – Breast cancer chemotherapy costs can vary by tens of thousands of dollars in the United States, depending on the course of treatment doctors select, a new study finds. Even across drug regimens that achieve the same effect, insurers' costs can differ by as much as $20,000, researchers found. They found a smaller variation in patients' share of the cost across different treatment regimens. "But there still was a high financial burden for patients," said Dr. Sharon Giordano, the study's lead author. That's especially true for patients in high-deductible health plans. Their median out-of-pocket cost exceeded $5,000, and 10 percent of patients shelled out $11,000 or more, the study found. Giordano is a professor in breast medical oncology and chair of health services research at the University of Texas MD Anderson Cancer Center in Houston. She and her colleagues ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Breast Cancer - Male

Breast Cancer Meds Won't Raise Chances of Heart Attack, Stroke, Study Suggests

Posted 21 Apr 2016 by Drugs.com

THURSDAY, April 21, 2016 – Treatment with estrogen-lowering drugs called aromatase inhibitors doesn't raise the risk of heart attacks and strokes among breast cancer survivors, a new study suggests. However, the researchers did find that women who took the drugs had a slightly higher risk of less serious heart problems, such as an abnormal heart beat or swelling and irritation of the membrane surrounding the heart. "Our study is a comprehensive assessment of the impact aromatase inhibitors have on cardiovascular risk and provides reassurance that the hormone therapy to reduce breast cancer recurrence does not increase risk of the most fatal cardiovascular events," said study author Reina Haque. She is a research scientist at Kaiser Permanente's Southern California Department of Research and Evaluation. "A particular strength of our study is that we accounted for women's other potential ... Read more

Related support groups: Heart Disease, Breast Cancer, Tamoxifen, Arimidex, Femara, Breast Cancer, Metastatic, Anastrozole, Letrozole, Aromasin, Exemestane, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Breast Cancer - Male, Tamoxifen Hexal, Soltamox, Testolactone, Tamone, Emblon, Tamoxen

Experts Issue Guidelines on Caring for Breast Cancer Survivors

Posted 7 Dec 2015 by Drugs.com

MONDAY, Dec. 7, 2015 – Battling breast cancer is tough, but survivors need care, too. Now, two major groups in cancer care have issued guidelines on the type of follow-up these patients require. The protocols, released jointly by the American Cancer Society and the American Society of Clinical Oncology, are "much needed for the 3.1 million breast cancer survivors who are alive in the United States today," said one expert, Dr. Eleonora Teplinsky, a medical oncologist with North Shore-LIJ Cancer Institute in Lake Success, N.Y. "Survivorship is defined as living with, through and beyond cancer, and each of these phases comes with unique concerns and challenges," she said. According to the new guidelines, regular monitoring of patients for the return of any cancer is one key recommendation. This monitoring should include evaluation – such as a detailed cancer history and physical ... Read more

Related support groups: Breast Cancer, Tamoxifen, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Breast Cancer - Male, Osteolytic Bone Metastases of Breast Cancer, Tamoxifen Hexal, Tamosin, Emblon, Nolvadex, Soltamox, Tamone, Tamoxen, Genox, Nolvadex D, Tamofen

More Men With Breast Cancer Having Second Breast Removed

Posted 2 Sep 2015 by Drugs.com

WEDNESDAY, Sept. 2, 2015 – There has been sharp rise in the number of American men with cancer in one breast who have surgery to remove their cancer-free breast, a new study said. The study authors said this is the first research to identify this trend in men, which has been occurring in American women for the past two decades. "The increase in the rate of this costly, serious procedure with no evidence of survival benefit comes, paradoxically, at a time of greater emphasis on quality and value in cancer care," said study leader Dr. Ahmedin Jemal, vice president of surveillance and health services research at the American Cancer Society. The study included more than 6,300 men who had surgery for cancer in one breast. Their surgeries occurred between 2004 and 2011. The percentage of men who also had their cancer-free breast removed rose from 3 percent in 2004 to 5.6 percent in 2011, the ... Read more

Related support groups: Surgery, Breast Cancer, Breast Cancer, Prevention, Breast Cancer - Male

Higher-Dose, Short-Duration Radiation Better for Early Breast Cancer: Study

Posted 6 Aug 2015 by Drugs.com

THURSDAY, Aug. 6, 2015 – A shorter course of radiation therapy is better for women with early stage breast cancer, according to a new study. Specifically, it found that those who received higher doses of whole breast radiation over a shorter period of time had fewer side effects and a better quality of life than those who received smaller doses of radiation over a longer period of time. "Patients who received the shorter course reported less difficulty in caring for their families' needs. This is a major priority for women undergoing breast cancer radiation," study first author Dr. Simona Shaitelman, from the University of Texas MD Anderson Cancer Center, said in a center news release. "Most are busy working mothers, working inside or outside the home, and are juggling a number of priorities. It's paramount that we address this need," explained Shaitelman, who is an assistant professor ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Breast Cancer - Male, Osteolytic Bone Metastases of Breast Cancer, History - Radiation Therapy

U.S. Oncologists Decry High Cost of Cancer Drugs

Posted 23 Jul 2015 by Drugs.com

THURSDAY, July 23, 2015 – Soaring costs for cancer drugs are hurting patient care in the United States, a group of top oncologists claim. "High cancer-drug prices are affecting the care of patients with cancer and our health care system," Dr. Ayalew Tefferi, a hematologist at Mayo Clinic in Rochester, Minn., said in a Mayo news release. Tefferi and his colleagues made a number of recommendations on how to address the problem in a commentary published July 23 in the Mayo Clinic Proceedings. Allowing Medicare to negotiate drug prices is one of the suggestions the team of 118 leading cancer experts offered as a possible solution. Along with their recommendations, the group also expressed support for a patient-based grassroots movement on change.org that is demanding action on the issue. "The average gross household income in the U.S. is about $52,000 per year. For an insured patient with ... Read more

Related support groups: Cancer, Depo-Provera, Provera, Methotrexate, Breast Cancer, Accutane, Lupron, Prostate Cancer, Medroxyprogesterone, Tamoxifen, Arimidex, Tretinoin, Fluorouracil, Lupron Depot, Femara, Lung Cancer, Gleevec, Rituxan, Renal Cell Carcinoma, Isotretinoin

Transgender People Do Not Face Higher Breast Cancer Risk, Study Shows

Posted 11 Mar 2015 by Drugs.com

WEDNESDAY, March 11, 2015 – While some may worry about the long-term health effects of hormonal therapy on transgender people, a new study finds no higher risk of breast cancer in this group than in the general population. Reporting in the journal LGBT Health, the analysis of U.S. veterans' medical records from 1998 to 2013 identified 10 cases of breast cancer in transgender people, according to study author Dr. George Brown, of Mountain Home VA Medical Center in Johnson City, Tenn. The breast cancers tended to be more advanced in people who were born as male and transitioned to female, compared to those who were born female and transitioned to male. Overall, however, transgender people appear to be at no higher odds for developing breast cancer. Speaking in a journal news release, Brown said that when groups of transgender and transsexual people are tracked over time, this has "not ... Read more

Related support groups: Microgestin Fe 1/20, Loestrin 24 Fe, Lo Loestrin Fe, Junel Fe 1/20, Gildess Fe 1/20, Microgestin 1/20, Necon 1/35, Prempro, Microgestin FE 1.5/30, Estratest, Generess Fe, Femhrt, Microgestin 1.5/30, Estradiol/Norethindrone, Angeliq, Ethinyl Estradiol/Norethindrone, Estradiol/Norgestimate, Activella, Estradiol/Levonorgestrel, Junel Fe 1.5/30

Male Breast Cancer Is Different

Posted 9 Dec 2014 by Drugs.com

TUESDAY, Dec. 9, 2014 – Men's breast cancer differs in some ways from women's, new research finds. One important difference is in the rates of survival. The study found that while survival for men with breast cancer has improved, it hasn't kept pace with the strides made in treating breast cancer in women. "Although we saw a significant improvement in overall survival for male breast cancer patients over time, the prognosis for men with breast cancer has not been improving as much as for women with the disease," Dr. Fatima Cardoso, director of the breast unit at the Champalimaud Cancer Center in Lisbon, Portugal, said in a news release from the American Association for Cancer Research. "This is largely because male breast cancer is a rare disease – it accounts for just 1 percent of breast cancers – and we know very little about its biology and how best to treat patients," Cardoso ... Read more

Related support groups: Breast Cancer - Male

Study Links Another Gene Variant to Male Breast Cancer

Posted 24 Sep 2012 by Drugs.com

SUNDAY, Sept. 23 – Researchers report that they've identified another genetic variation that appears connected to male breast cancer, a rare condition that kills several hundred men in the United States each year. The finding won't immediately lead to any improvements in treatment for the disease. Still, "by finding more male breast cancer genes, we can understand more about the biology of the disease and, as a result, get a better understanding of how best to treat male breast cancer," said study author Dr. Nick Orr, a team leader at the Institute of Cancer Research in London. "We hope these findings will also help us to learn more about how the disease works in women, too." Male breast cancer is about 100 times less common than female breast cancer, according to the American Cancer Society. It estimates that this year breast cancer will be diagnosed in about 2,190 men in the United ... Read more

Related support groups: Breast Cancer - Male

Men's Breast Cancer Often More Deadly, Study Suggests

Posted 4 May 2012 by Drugs.com

FRIDAY, May 4 – Breast cancer in men is much less common than it is in women, but it may be more deadly, new research suggests. "Men with breast cancer don't do as well as women with breast cancer, and there are opportunities to improve that," said study author Dr. Jon Greif, a breast surgeon in San Francisco. "They were less likely to get the standard treatments that women get." Survival rates for men with breast cancer, overall, are lower than those for women, at least when it is diagnosed in the early stages, Greif found. The cancers differ in other respects too. Greif was scheduled to present his findings Friday at the American Society of Breast Surgeons annual meeting in Phoenix. Greif and his team warn, however, that some of the differences they found may not bear out in clinical practice. A big limitation to the research: The database they drew from keeps track of which breast ... Read more

Related support groups: Breast Cancer - Male

Side Effects May Spur Men to Drop Tamoxifen for Breast Cancer

Posted 16 Nov 2011 by Drugs.com

WEDNESDAY, Nov. 16 – One in five male breast cancer patients stops taking the drug tamoxifen early due to side effects caused by the medicine and may be at increased risk for cancer recurrence, new research suggests. Tamoxifen is the standard of care for the hormone treatment of male breast cancer patients, according to the authors of a new report published in the Nov. 16 issue of the Annals of Oncology. In the study, researchers at the University of Texas M.D. Anderson Cancer Center in Houston examined the records of 64 male breast cancer patients who received tamoxifen for an average of four years and found that 34 of them (53 percent) experienced one or more tamoxifen-related side effects, such as weight gain and loss of sex drive. Thirteen (20.3 percent) of the patients stopped taking tamoxifen due to the side effects. Nine of the patients died after they discontinued tamoxifen ... Read more

Related support groups: Tamoxifen, Breast Cancer - Male, Tamoxifen Hexal, Tamosin, Emblon, Nolvadex, Soltamox, Tamone, Tamoxen, Genox, Nolvadex D, Tamofen

Page 1 2 Next

Ask a Question

Further Information

Related Condition Support Groups

Breast Cancer

Related Drug Support Groups

tamoxifen, Tamoxifen Hexal, Tamosin, Genox, Tamoxen, Nolvadex D, Tamofen, Nolvadex, Soltamox, Tamone, Emblon